[1] |
LUO Fangmei, WU Pan, LI Jing, WANG Ting, WANG Fangjie.
Correlations of ABCB1 C3435T genetic polymorphism with serum concentrations and adverse reactions of high-dose methotrexate in children with mature B-cell lymphoma
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 675-679.
|
[2] |
HUANG Yinyin, ZHANG Liwen, LIU Jing, CHEN Jing, ZHOU Yuanhua, XU Mingzhe, YAO Shangchen, WANG Chen, ZHANG Xianhua.
Preparation, characterization and stability of three forms of prulifloxacin
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 374-378.
|
[3] |
YANG Caihua, YANG Longna, LI Xiaobo.
Two cases of fetal malformation after exposure to low dose warfarin sodium tablets in early pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1286-1289.
|
[4] |
ZHANG Wenwen, NIE Xiting, XU Huiru, RAN Ye, TIAN Chenglin, YU Shengyuan.
One case of extremely abnormal coagulation caused by warfarin combined with compound paracetamol and amantadine hydrochloride tablets
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1290-1292.
|
[5] |
LIU Tiantian, CAO Junling, ZHANG Yanli, GONG Ying, GU Yuanyuan.
Research progress in enhancing anticoagulant effects of warfarin and the mechanism by traditional Chinese medicine for promoting blood circulation and removing blood stasis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 117-120.
|
[6] |
WEN Dusu, SUN Jianjun, WANG Yi.
Safety and efficacy of participation of pharmacists in warfarin anticoagulation therapy:a Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1009-1014.
|
[7] |
XIANG Yunxia, PU Wen, LI Dongfeng, WANG Jie.
Effects of pharmacists' intervention on anticoagulant management of patients treated with warfarin after heart valve replacement
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 545-549.
|
[8] |
LI Yu, FAN Huihui, FENG Xiaojun, ZHANG Yonghuang, CHEN Qin, WANG Yunhong, CHEN Chuantao, ZHANG Lei, SHI Tianlu.
Association between ABCB1 C3435T polymorphisms and methotrexate-induced toxicity in childhood acute lymphoblastic leukemia: Meta analysis
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 421-425.
|
[9] |
GUO Jun, REN Dan, YE Long, ZHAO Rongxiang, WANG Yu, YU Jing.
Spontaneous muscular hemorrhage induced by warfarin tablets in a child
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 339-341.
|
[10] |
WU Ting, LYV Xiaoqin.
Drug-induced Liver Injury Caused by Warfarin
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(4): 365-367.
|
[11] |
MEI Dan, LU Junguo, GU Haijuan, NI Meixin.
Serious Delayed Diarrhea Induced by IRIS Regimen in an UGT1A1-wild-genotype Patient
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(6): 373-376.
|
[12] |
BAI Hehe, NIE Xiaojing, XIA Li, ZHAO Meng, WANG Jinping, YAO Yanqin.
Analysis of One Case of Warfarin Related Nephropathy
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 934-938.
|
[13] |
LI Yu, FAN Huihui, FENG Xiaojun, WANG Yunhong, CHEN Chuantao, ZHANG Lei.
Individualized Anticoagulant Therapy for Warfarin in a Patient with Poor Metabolism
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 939-942.
|
[14] |
LUO Min, XU Ting.
One Case Analysis of Antibacterial Agents Interaction with Warfarin after Transcatheter Aortic Valve Implantation
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(9): 555-558.
|
[15] |
ZHANG Ya-tong, ZHU Kong-cai, ZHAO Ming, ZHAO Zi-nan, LI Zheng, HE Yi-jun.
Effect of SLCO1B1 Gene Polymorphism on Lipid - Lowering Effect of Atorvastatin
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(5): 274-277.
|